These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11800172)

  • 1. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
    Thiebaud D; Secrest RJ
    Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects.
    Muchmore DB
    Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
    Musa MA; Khan MO; Cooperwood JS
    Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
    Park WC; Jordan VC
    Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
    Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS
    J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen receptor modulators.
    Haskell SG
    South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.
    Peng J; Sengupta S; Jordan VC
    Anticancer Agents Med Chem; 2009 Jun; 9(5):481-99. PubMed ID: 19519291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacological review of selective oestrogen receptor modulators.
    Goldstein SR; Siddhanti S; Ciaccia AV; Plouffe L
    Hum Reprod Update; 2000; 6(3):212-24. PubMed ID: 10874566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiovascular effects of selective estrogen receptor modulators.
    Christodoulakos GE; Lambrinoudaki IV; Botsis DC
    Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective oestrogen receptor modulators in desmoid tumours.
    Picariello L; Tonelli F; Brandi ML
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1457-68. PubMed ID: 15500393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of selective estrogen receptor modulators on estrogen-sensitive tissues].
    Jirecek S; Pavo I; Huber JC
    Gynakol Geburtshilfliche Rundsch; 1999; 39(4):184-90. PubMed ID: 10629380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of raloxifene hydrochloride.
    Saitta A; Morabito N; Frisina N; Cucinotte D; Corrado F; D'Anna R; Altavilla D; Squadrito G; Minutoli L; Arcoraci V; Cancellieri F; Squadrito F
    Cardiovasc Drug Rev; 2001; 19(1):57-74. PubMed ID: 11314601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen receptor modulators: a look ahead.
    Mitlak BH; Cohen FJ
    Drugs; 1999 May; 57(5):653-63. PubMed ID: 10353293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
    Landry M; Di Paolo T
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation.
    Bryant HU
    Rev Endocr Metab Disord; 2001 Jan; 2(1):129-38. PubMed ID: 11704975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene.
    Overk CR; Peng KW; Asghodom RT; Kastrati I; Lantvit DD; Qin Z; Frasor J; Bolton JL; Thatcher GR
    ChemMedChem; 2007 Oct; 2(10):1520-6. PubMed ID: 17654759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.